首页> 外文会议>Congress of the International Pig Veterinary Society >EFFICACY OF CEFQUINOME (COBACTAN~(R) 2.5) IN THE TREATMENT OF STREPTOCOCCUS SV1S EXPERIMENTALLY INDUCED MENINGITIS IN PIGLETS
【24h】

EFFICACY OF CEFQUINOME (COBACTAN~(R) 2.5) IN THE TREATMENT OF STREPTOCOCCUS SV1S EXPERIMENTALLY INDUCED MENINGITIS IN PIGLETS

机译:cefquinome的功效(Cobactan〜(R)2.5%)治疗链球菌SV1s实验诱导仔猪中的脑膜炎

获取原文

摘要

Streptococcus suis (S. suis) is an important swine pathogen, which leads in weaning piglets to meningitis, arthritis or septicemia [1], At the moment successful protection strategies are not broadly available and curative intervention is often required. Late generation cephalosporins are generally good candidates for the treatment of human bacterial meningitis [2]. The 4th generation cephalosporin cefquinorne (INN) has a potential use in the treatment of bacterial meningitis in pigs as caused by S.suis serotype 2 [2]. S. suis is highly susceptible to cefquinorne with a MIC 90 = 0.03 mu g/ml. This study reports the curative efficacy of cefquinorne (Cobactan~(R) 2.5%) in the induced S.suis meningitis in piglets.
机译:链球菌Suis(Suis)是一种重要的猪病原体,它导致脑膜炎的断奶仔猪,关节炎或败血症[1],目前,成功的保护策略不受广泛的可用性,并且通常需要治疗干预。晚生成的头孢菌素通常是治疗人细菌性脑膜炎的良好候选者[2]。第四代头孢菌素Cefquinorne(Inn)在猪中潜在地用于治疗猪中的细菌性脑膜炎,如S.Suis Serotype 2 [2]。 S. Suis高易受Cefquinorne的Cefquinorne,MIC 90 =0.03μg/ ml。本研究报告了CEFQUINORNE(COBACTAN〜(R)2.5%)在仔猪诱导的S.Suis脑膜炎中的治疗疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号